SLC1A5 and gastric cancer: Among these, SLC1A5 (also known as ASCT2) serves as the primary transporter for glutamine, with its overexpression strongly linked to the growth, metastasis, and drug resistance of several cancers, including breast, lung, liver, and gastric cancers (29–31).